Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013

Clinverse’s eClinical Commerce Network is the industry’s first and only fully configurable, cloud-based clinical financial lifecycle system.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Raleigh, NC (PRWEB) June 19, 2013

Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, today announced it will be exhibiting and showcasing its technology at DIA 2013 (booth #2000) in Boston, June 24-26, 2013. Clinverse’s eClinical Commerce Network is the industry’s first and only fully configurable, cloud-based clinical financial lifecycle system.

Clinverse’s patent-pending technology, ClinPay®, the flagship module within Clinverse’s eClinical Commerce Network, automates site contract set-up and management, contract term translation, investigator payments and all the GAAP accounting and financial reporting across the entire lifecycle of a clinical trial while ending the need for any post-study reconciliation. Earlier this month, Clinverse introduced ClinSpend™, a new module for aggregating and reporting compliant data to the appropriate entity responsible for OPEN PAYMENTS (formerly know as Sunshine Act) reporting.

DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. This annual meeting provides thought leaders, decision-makers and patient advocates with the opportunity to collaborate and share knowledge with the top minds in medicine.

In addition to exhibiting at DIA, Clinverse is hosting a free webcast on Wednesday, June 19 at 2:00 pm ET titled “The Sun Has Risen on the Sunshine Act: Understanding the Challenges of Complying with the National Physician Payment Transparency Program.” With over 100 attendees from throughout BioPharma already signed up to attend, the webcast will serve as a forum for attendees to learn about the requirements associated with OPEN PAYMENTS and hear best practices for compliance.

Presenters include:

  •     Steve Ayala, President and Head of Partnerships, Clinverse, Inc.
  •     John Lewis, CEO, Aggregate Spend Solutions, LLC
  •     Ami Patel, Attorney in the FDA & Life Sciences Practice Group at the international law firm of King & Spalding

To register for the webcast, visit: http://ow.ly/lJWKY..

If you are interested in scheduling a time to learn more about Clinverse’s technology while at DIA 2013, please call 1.877.325.1122 or email info(at)clinverse(dot)com.

About Clinverse, Inc.
Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay® FLS, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit http://www.clinverse.com.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn